Insights

Expanding Therapeutic Reach ADVANZ PHARMA's diverse portfolio across therapeutic areas such as hepatology, gastroenterology, and rare diseases presents opportunities to collaborate with healthcare providers and hospitals that specialize in these fields, expanding sales in niche medical segments.

Strategic Market Presence With direct commercial operations in over 20 countries and a focus on Europe, Canada, and Australia, there is potential to leverage existing regional networks to introduce new formulations, biosimilars, or generic medicines to key healthcare markets.

Innovative Product Launches The recent launch of Mytolac, a first generic lanreotide for acromegaly, indicates opportunities to target specialized clinics and endocrinologists, creating avenues for upselling other specialty or biosimilar products.

Partnership Expansion Ongoing collaborations with firms like Altamira Therapeutics, Veeva, and local partners demonstrate an openness to strategic alliances, which could be harnessed to access new customer segments and expand distribution channels for complementary medicines.

Digital Transformation Opportunities ADVANZ PHARMA’s adoption of digital platforms like Veeva Systems suggests readiness for targeted digital marketing and direct engagement strategies, providing avenues to generate demand and strengthen relationships with healthcare professionals.

ADVANZ PHARMA Tech Stack

ADVANZ PHARMA uses 8 technology products and services including SAP FICO, GDPR, Cybot, and more. Explore ADVANZ PHARMA's tech stack below.

  • SAP FICO
    Accounting
  • GDPR
    Certificates
  • Cybot
    Cookie Compliance
  • Cookiebot
    Cookie Compliance
  • Anaplan
    Corporate Performance Management
  • Mailchimp
    Email
  • SAP ERP
    Enterprise Resource Planning
  • GoDaddy
    Web Hosting

Media & News

ADVANZ PHARMA's Email Address Formats

ADVANZ PHARMA uses at least 1 format(s):
ADVANZ PHARMA Email FormatsExamplePercentage
First.Last@advanzpharma.comJohn.Doe@advanzpharma.com
97%
First.Middle@advanzpharma.comJohn.Michael@advanzpharma.com
2%
Middle@advanzpharma.comMichael@advanzpharma.com
1%

Frequently Asked Questions

Where is ADVANZ PHARMA's headquarters located?

Minus sign iconPlus sign icon
ADVANZ PHARMA's main headquarters is located at Dashwood House, 2nd Floor, 69 Old Broad Street London, England EC2M 1QS, GB. The company has employees across 5 continents, including AsiaEuropeNorth America.

What is ADVANZ PHARMA's official website and social media links?

Minus sign iconPlus sign icon
ADVANZ PHARMA's official website is advanzpharma.com and has social profiles on LinkedInCrunchbase.

What is ADVANZ PHARMA's NAICS code?

Minus sign iconPlus sign icon
ADVANZ PHARMA's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ADVANZ PHARMA have currently?

Minus sign iconPlus sign icon
As of October 2025, ADVANZ PHARMA has approximately 695 employees across 5 continents, including AsiaEuropeNorth America. Key team members include Chief Financial Officer: A. S.Chief Commercial Officer: S. T.Chief Transformation Officer: A. N.. Explore ADVANZ PHARMA's employee directory with LeadIQ.

What industry does ADVANZ PHARMA belong to?

Minus sign iconPlus sign icon
ADVANZ PHARMA operates in the Pharmaceutical Manufacturing industry.

What technology does ADVANZ PHARMA use?

Minus sign iconPlus sign icon
ADVANZ PHARMA's tech stack includes SAP FICOGDPRCybotCookiebotAnaplanMailchimpSAP ERPGoDaddy.

What is ADVANZ PHARMA's email format?

Minus sign iconPlus sign icon
ADVANZ PHARMA's email format typically follows the pattern of First.Last@advanzpharma.com. Find more ADVANZ PHARMA email formats with LeadIQ.

How much funding has ADVANZ PHARMA raised to date?

Minus sign iconPlus sign icon
As of October 2025, ADVANZ PHARMA has raised $1.2B in funding. The last funding round occurred on Apr 10, 2025 for $1.2B.
ADVANZ PHARMA

ADVANZ PHARMA

Pharmaceutical ManufacturingUnited Kingdom501-1000 Employees

Partner of choice in specialty, hospital, and rare disease medicines

ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on.

Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients.

Headquartered in London, UK, we have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia. Our Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network complement our global operations.

ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, specialty generics & biosimilars, and originator brands. Our products and pipeline cover a broad range of therapeutic areas, including hepatology, gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more broadly, rare diseases.

We can only achieve our ambition with the passion of our dedicated and highly qualified people, acting in line with our company values of entrepreneurship, speed, and integrity.

Section iconCompany Overview

Headquarters
Dashwood House, 2nd Floor, 69 Old Broad Street London, England EC2M 1QS, GB
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $1.2B

    ADVANZ PHARMA has raised a total of $1.2B of funding over 4 rounds. Their latest funding round was raised on Apr 10, 2025 in the amount of $1.2B.

  • $50M$100M

    ADVANZ PHARMA's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $1.2B

    ADVANZ PHARMA has raised a total of $1.2B of funding over 4 rounds. Their latest funding round was raised on Apr 10, 2025 in the amount of $1.2B.

  • $50M$100M

    ADVANZ PHARMA's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.